J. R. Healthcare Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 10-12-2024
- Paid Up Capital ₹ 0.10 M
as on 10-12-2024
- Company Age 11 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 1.80 Cr
as on 10-12-2024
- Revenue %
(FY 2022)
- Ebitda
- Net Worth 48.57%
(FY 2022)
- Total Assets 0.51%
(FY 2022)
About J. R. Healthcare
The Company is engaged in the Financial Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹1.80 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Nalin Agarwal, Subhash Agarwal, and Megha Agarwal serve as directors at the Company.
- CIN/LLPIN
U85191UP2013PTC054982
- Company No.
054982
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Feb 2013
- Date of AGM
02 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Meerut, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at J. R. Healthcare?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nalin Agarwal  | Director | 02-Sep-2024 | Current |
| Subhash Agarwal | Director | 13-Feb-2013 | Current |
| Megha Agarwal | Director | 02-Sep-2024 | Current |
Financial Performance and Corporate Structure Insights of J. R. Healthcare.
J. R. Healthcare Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth Soared by an impressive increase of 48.57%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of J. R. Healthcare?
In 2020, J. R. Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Mann Agrofarms LimitedActive 9 years 1 monthNalin Agarwal, Subhash Agarwal and 1 more are mutual person
- Deepali Pharmaceuticals Private LimitedActive 23 years 1 month
Nalin Agarwal and Megha Agarwal are mutual person
- Sav Pharmaceuticals LimitedActive 27 years 1 month
Nalin Agarwal and Megha Agarwal are mutual person
- Vaidyanta Research India Private LimitedActive 10 years 10 months
Subhash Agarwal is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Punjab National Bank Creation Date: 14 Feb 2013 | ₹1.80 Cr | Satisfied |
How Many Employees Work at J. R. Healthcare?
Unlock and access historical data on people associated with J. R. Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of J. R. Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped J. R. Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
